Diabetes Clinical Trials

The Allen Diabetes Center at Hoag maintains a strong clinical and psychosocial research program with a primary objective of improving the lives of people with diabetes. We maintain multidisciplinary collaborations with a variety of organizations including academic institutions, industry, and charitable foundations. Our research team maintains a strong publication record and is regularly invited to present their study findings at national conferences and other scientific meetings.

Currently, the following projects are underway:

Study Title: Connected Pens for Diabetes Study (CUPID)

  • This is a study looking at whether a new FDA-approved insulin pen device can help people with diabetes better manage their blood sugar. This insulin pen pairs with an smartphone app to suggest an appropriate dose of insulin for the user to take, and automatically keeps a record of the insulin doses administered. Researchers will gather data to assess if this new insulin pen device and corresponding dose advisor app improve diabetes management in study participants.
  • Trial Flyer

Study Title: Transition to adult care in type 1 diabetes – Understanding needs, expectations, and experiences of emerging adults, parents, and healthcare professionals.

  • This project has been designed to understand concerns and expectations of T1D patients, their families, and providers regarding the transition process from a national sample of stakeholders. Study findings will subsequently help develop recommendations to implement a comprehensive and patient-centered transition process for emerging adults with T1D.
  • Study Survey for Young Adults with T1D
  • Study Survey for Parents of Young Adults with T1D

Study title: Feasibility and preliminary efficacy of a telehealth intervention to augment clinical and psychosocial management of gestational diabetes in a randomized cohort of ethnically diverse patients.

  • This project has the potential to improve care delivery and self-management for women with gestational diabetes by offering them quick and convenient access to their diabetes care teams when needed.

To learn more about available clinical trials, please contact us.